Generated by AI
Stereotaxis Inc. is a cutting-edge medical technology company that specializes in robotic systems for minimally invasive surgery. The company's primary focus is on the development and commercialization of robotic navigation technologies designed to enhance the precision, safety, and efficiency of procedures within the cardiac arrhythmia treatment sector. Stereotaxis' flagship product, the Niobe Magnetic Navigation System, enables physicians to maneuver catheters with a high degree of accuracy, using magnetic fields to decrease potential complications associated with traditional manual techniques. This technology significantly impacts the healthcare sector, particularly hospitals and medical centers specializing in interventional cardiology, by improving patient outcomes and operational workflows. Based in St. Louis, Missouri, Stereotaxis plays a significant role in advancing the field of robotic surgery, contributing to the broader medical device market's growth and innovation.
Website710 North Tucker Boulevard
Saint Louis, MO, 63101
United States
The latest articles about STXS.
Stereotaxis Inc (STXS) posted $8.9 million in Q3 2026 revenue and a 60% surge in system sales, yet a $1.9 million catheter backlog and thin cash position cloud the path to profitability.
Summary of Nov 11's posts. Generated by AI.
Summary of Feb 2's posts. Generated by AI.
Summary of Jul 17's posts. Generated by AI.
Investors talking about STXS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.